Drug Trial Radar · NCT06699628
Phase I Trial Evaluating the Pharmacokinetics of Single Ascending Oral Doses of IRL757 in Healthy Elderly Volunteers
Last checked: Nov 19, 2026Latest source record: Feb 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
12
Actual
Start
Sep 23, 2024
Primary completion
Nov 11, 2024
Study completion Nov 11, 2024
Sponsor
- Lead sponsor
- Integrative Research Laboratories ABIndustry
- Sponsor type
- Industry
- First posted
- Nov 21, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 65 years, up to 89 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a phase I trial evaluating the pharmacokinetics of single ascending oral doses of IRL757 in healthy elderly volunteers.
Conditions
- Not Applicable as This is a Mass Balance/Pharmacokinetic Study Performed in Healthy Subjects
- Apathy
Interventions
IRL757Drug
IRL757 capsules
Primary outcomes
What the sponsor says the trial is designed to measure.
- Determination of Maximum Plasma Concentration [Cmax] of IRL757Time frame: PK followed until 48 hours
- Determination of the AUC of IRL757 and Its Main MetabolitesTime frame: PK followed until 48 hours
- Determination of the Time for Maximum Concentration [Tmax] of IRL757 and Its Main MetabolitesTime frame: PK followed until 48 hours
- Determination of the Half-life [t1/2] of IRL757 and Its Main MetabolitesTime frame: PK followed until 48 hours
- Determination of the Renal Clearance (CLr) of IRL757Time frame: PK followed until 48 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
CTC Clinical Trial Consultants AB
Uppsala, Sweden
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.